Related Experiment Video
Updated: Jun 4, 2026
09:39
Procedure for Fabricating Biofunctional Nanofibers
Published on: September 10, 2012
Carbohydrate modified ultrafine ceramic nanoparticles for allergen immunotherapy
Ravi Shankar Pandey1, Satish Sahu, M S Sudheesh
1Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Vishwavidyalaya, Sagar, M.P. 470003, India.
International Immunopharmacology
|February 22, 2011
Summary
Aquasomes, a novel drug-delivery system, show promise in allergen immunotherapy by acting as effective adjuvants. This study found aquasomes reduced allergic reactions and improved outcomes compared to traditional aluminum hydroxide treatments.
Area of Science:
- Immunology
- Nanotechnology
- Drug Delivery Systems
Background:
- Allergen-specific immunotherapy (AIT) benefits from drug-delivery systems that enhance efficacy and reduce administration frequency.
- Aquasomes, carbohydrate-modified ceramic nanoparticles, are explored as potential adjuvants and delivery vehicles for AIT.
Purpose of the Study:
- To evaluate aquasomes as an adjuvant/delivery vehicle for ovalbumin (OVA)-specific immunotherapy.
- To characterize OVA-adsorbed aquasomes and assess their immunogenicity and therapeutic potential in a murine model.
Main Methods:
- Aquasomes were synthesized and characterized for physical properties and OVA adsorption efficiency.
- Humoral and cellular immune responses were evaluated after intradermal immunization in BALB/c mice.
- OVA-sensitized mice were treated with OVA-aquasomes or OVA-aluminum hydroxide, followed by OVA challenge to assess anaphylaxis.
Main Results:
- Developed aquasomes exhibited optimal size (47 nm), negative zeta potential (-11.3 mV), and efficient OVA adsorption (~60.2 μg mg⁻¹).
- Intradermal OVA-aquasomes induced a mixed Th1/Th2 immune response.
- Treatment with OVA-aquasomes significantly reduced IgE levels, serum histamine, and anaphylactic shock symptoms compared to alum-adsorbed OVA, while increasing survival rates.
Conclusions:
- Aquasomes demonstrate significant potential as effective adjuvant and delivery systems for allergen-specific immunotherapy.
- The use of aquasomes in AIT offers an improved safety profile and therapeutic efficacy over conventional adjuvants like aluminum hydroxide.
